News
2d
News-Medical.Net on MSNResearch highlights an increase in informal use of doxyPEP/PrEP among key populations in the NetherlandsNew research analyzing an online survey of 1,633 respondents found 15% recent use of doxycycline post- and pre-exposure ...
5mon
Queerty on MSNMore good news about DoxyPEP - MSNDoxyPEP is short for Doxycycline Post-Exposure Prophylaxis. It involves taking a single 200 mg dose of the antibiotic ...
Of nearly 12,000 people being treated for HIV, nearly one in five -- more than 2,250 -- received doxyPEP within its first year of availability, researchers found.. The team then looked at STI test ...
In San Francisco, cases of chlamydia and early syphilis fell steadily and were roughly halved at the 13-month mark after implementation of doxyPEP in the city, one report showed, while at Kaiser ...
DoxyPEP users had a higher risk of an STI compared with non users (OR, 5.33; 95% CI, 4.11-6.90) before they started using DoxyPEP. This risk decreased after initiation, ...
While some STI symptoms, such as vaginal discharge, ulcers, and burning, are common, others may be more subtle or ...
Informal doxyPEP/PrEP use associated with HIV PrEP use, sexualised drug use and perception of safety. As highlighted by this paper and an accompanying editorial by Lyons et al. [2], ...
The researchers found that 19.5% were dispensed doxyPEP, which was associated with older age (mean age, 40.4 vs 39.8 years), longer HIV PrEP use (mean, 4.2 vs 3.4 years), and a higher proportion ...
DoxyPEP offers a promising form of harm reduction. It’s cheap and well-tolerated, and it can easily be folded into many gay and bisexual men’s routines for receiving prescriptions to treat or ...
Last month, the Centers for Disease Control and Prevention issued guidelines for the use of doxycycline after sex — as post-exposure prophylaxis, or doxyPEP — to lower the risk of bacterial ...
It says that wider use of DoxyPEP could have “substantial benefits” for bringing down STI rates. San Francisco allowed clinics to start prescribing DoxyPEP in late 2022.
Of nearly 12,000 people being treated for HIV, nearly one in five -- more than 2,250 -- received doxyPEP within its first year of availability, researchers found. Advertisement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results